This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

Optum, Mayo Clinic Partner To Launch Optum Labs: An Open, Collaborative Research And Innovation Facility Focused On Better Care For Patients

Stocks in this article: UNH

Optum and Mayo Clinic today jointly launched Optum Labs, an open, collaborative research and development facility with a singular goal: improving patient care. Based in Cambridge, Mass., Optum Labs provides an environment where the health care industry can come together to combine information and ideas that benefit patients today while also driving long-term improvements in the delivery and quality of care.

Optum and Mayo Clinic will make their information assets, technologies, knowledge tools and scientific expertise available to organizations interested in pursuing practical new solutions to patient care challenges. As the first and largest integrated, not-for-profit medical group practice in the world, Mayo Clinic will also contribute valuable insights directly from patient experiences. Mayo Clinic’s extensive clinical expertise will be instrumental in guiding Optum Labs’ research agenda and applying research results and insights directly to the patient care environment. Combining Mayo Clinic’s extensive clinical insights with Optum’s health care claims information will help doctors better understand all aspects of the patient care experience and refine approaches to care that consistently help patients achieve the best outcomes. Other Optum Labs participants will include academic institutions, life sciences companies, commercial and government payers, and other care providers.

“As a founding partner of Optum Labs, Mayo Clinic is excited to work with Optum and other organizations to address the challenges and issues facing health care in order to help us provide better care to our patients, and help lead improvements to the delivery of care,” said John Noseworthy, M.D., president and chief executive officer of Mayo Clinic. “Our strategic research alliance with Optum Labs will leverage what we believe to be the largest combined source of clinical and claims information, providing a more comprehensive picture of patients’ diagnoses, progression of diseases, comparative treatments and outcomes.”

“We are privileged to introduce Optum Labs in partnership with Mayo Clinic, which has been improving health outcomes for 150 years by continually researching, discovering and doing what’s best for the patient,” said Larry Renfro, chief executive officer of Optum. “Mayo Clinic and Optum are bringing together the best clinical insight, health information and research expertise to drive innovation that works for care providers and the patients they serve. We also welcome and look forward to the perspectives, ideas and contributions of future participants from across the health care system who share the goal of creating a better future for patient care.”

1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,831.49 +21.43 0.12%
S&P 500 2,067.84 +4.34 0.21%
NASDAQ 4,738.1840 +25.2140 0.54%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs